Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 4
1977 5
1978 3
1979 3
1980 4
1981 4
1982 10
1983 9
1984 9
1985 6
1986 4
1987 8
1988 4
1989 1
1990 14
1991 7
1992 8
1993 15
1994 17
1995 7
1996 13
1997 8
1998 10
1999 18
2000 13
2001 18
2002 10
2003 19
2004 20
2005 17
2006 34
2007 38
2008 42
2009 27
2010 25
2011 14
2012 12
2013 9
2014 11
2015 10
2016 5
2017 6
2018 9
2019 7
2020 9
2021 4
2022 8
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

529 results

Results by year

Filters applied: . Clear all
Page 1
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA. Motzer RJ, et al. Among authors: bukowski rm. N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044. N Engl J Med. 2007. PMID: 17215529 Free article. Clinical Trial.
Pazopanib.
Bukowski RM, Yasothan U, Kirkpatrick P. Bukowski RM, et al. Nat Rev Drug Discov. 2010 Jan;9(1):17-8. doi: 10.1038/nrd3073. Nat Rev Drug Discov. 2010. PMID: 20043026
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.
Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Heng DY, et al. Among authors: bukowski rm. J Clin Oncol. 2009 Dec 1;27(34):5794-9. doi: 10.1200/JCO.2008.21.4809. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826129
Hydrops fetalis.
Bukowski R, Saade GR. Bukowski R, et al. Clin Perinatol. 2000 Dec;27(4):1007-31. doi: 10.1016/s0095-5108(05)70061-0. Clin Perinatol. 2000. PMID: 11816486 Review.
SPLEEN/PATHOL.
Bukowski RM, Noguchi S, Hewlett JS, Deodhar S. Bukowski RM, et al. Am J Clin Pathol. 1976 Jan;65(1):30-9. Am J Clin Pathol. 1976. PMID: 1082240
Intrauterine growth restriction.
Haram K, Søfteland E, Bukowski R. Haram K, et al. Among authors: bukowski r. Int J Gynaecol Obstet. 2006 Apr;93(1):5-12. doi: 10.1016/j.ijgo.2005.11.011. Epub 2006 Feb 8. Int J Gynaecol Obstet. 2006. PMID: 16469319 Review.
The role of inflammation in kidney cancer.
de Vivar Chevez AR, Finke J, Bukowski R. de Vivar Chevez AR, et al. Among authors: bukowski r. Adv Exp Med Biol. 2014;816:197-234. doi: 10.1007/978-3-0348-0837-8_9. Adv Exp Med Biol. 2014. PMID: 24818725 Review.
RANK ligand: effects of inhibition.
George S, Brenner A, Sarantopoulos J, Bukowski RM. George S, et al. Among authors: bukowski rm. Curr Oncol Rep. 2010 Mar;12(2):80-6. doi: 10.1007/s11912-010-0088-1. Curr Oncol Rep. 2010. PMID: 20425591 Review.
Work-up of stillbirth: a review of the evidence.
Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, Dudley D, Saade G, Stoll B. Silver RM, et al. Among authors: bukowski r. Am J Obstet Gynecol. 2007 May;196(5):433-44. doi: 10.1016/j.ajog.2006.11.041. Am J Obstet Gynecol. 2007. PMID: 17466694 Free PMC article. Review.
Immunotherapy in renal cell carcinoma.
Bukowski RM. Bukowski RM. Oncology (Williston Park). 1999 Jun;13(6):801-10; discussion 810, 813. Oncology (Williston Park). 1999. PMID: 10378218 Free article. Review.
529 results